Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Zwinderman

Showing results (371-380 of 397) with videos related to

Pageof 40
Sort By:
Arthritis and Rheumatism|May 20, 1998
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study GroupM A van Rossum, T J Fiselier, M J Franssen, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
AJNR. American Journal of Neuroradiology|September 9, 2017
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-AnalysisN Verburg, F W A Hoefnagels, F Barkhof, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 26, 2022
Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohortM van Barreveld, T E Verstraelen, E Buskens, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 10, 2025
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysisM van Barreveld, P F H M van Dessel, E Buskens, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Journal of Medical Genetics|May 23, 2001
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigreeA Wagner, Y Hendriks, E J Meijers-Heijboer, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Genes and Immunity|November 24, 2006
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary interventionP S Monraats, F A S Kurreeman, D Pons, et al.
BMJ Open|March 25, 2014
Rationale and cross-sectional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM studyCharles Agyemang, Erik Beune, Karlijn Meeks, et al.
Pageof 40

Showing results (371-380 of 397) with videos related to

Sort By:
Pageof 40
Arthritis and Rheumatism|May 20, 1998
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study GroupM A van Rossum, T J Fiselier, M J Franssen, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
AJNR. American Journal of Neuroradiology|September 9, 2017
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-AnalysisN Verburg, F W A Hoefnagels, F Barkhof, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 26, 2022
Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohortM van Barreveld, T E Verstraelen, E Buskens, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 10, 2025
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysisM van Barreveld, P F H M van Dessel, E Buskens, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Journal of Medical Genetics|May 23, 2001
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigreeA Wagner, Y Hendriks, E J Meijers-Heijboer, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Genes and Immunity|November 24, 2006
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary interventionP S Monraats, F A S Kurreeman, D Pons, et al.
BMJ Open|March 25, 2014
Rationale and cross-sectional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM studyCharles Agyemang, Erik Beune, Karlijn Meeks, et al.
Pageof 40